| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.31 | 0.3 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |